Tuesday, April 7, 2026 – Wednesday April 8 - The FDA has approved a new once-daily GLP-1 pill for weight loss. Image Credit: Healthline/Photo by Eli Lilly
Federal regulators have approved the GLP-1 tablet Foundayo for use in weight management.
Experts say having another weight loss medication in pill form could help people stick to a weight management regimen.
Monday, April 6, 2026 – MONDAY, April 6, 2026 -- Ixekizumab plus tirzepatide (IXE+TZP) shows significant benefits for outcomes in psoriatic arthritis (PsA) versus IXE alone in adults with overweight or obesity, according to a study presented at the annual meeting of the...
Monday, April 6, 2026 – Tuesday, April 7 - Combat muscle loss with this 7-move routine.
Monday, April 6, 2026 – Tuesday, April 7 - Ixekizumab plus tirzepatide (IXE+TZP) shows significant benefits for outcomes in psoriatic arthritis (PsA) versus IXE alone in adults with overweight or obesity, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 27 to 31 in Denver.
Monday, April 6, 2026 – Tuesday, April 7 - Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella review draws attention to safety concerns regarding the use of this GLP medication, alongside a mix of potential benefits.
Saturday, April 4, 2026 – Sunday, April 5 - (MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical...
Thursday, April 2, 2026 – Friday, April 3 - PLAINSBORO, NJ and BAGSVÆRD, Denmark, April 2, 2026 /PRNewswire/ -- Novo Nordisk will present the ORION study at the upcoming Obesity Medicine Association’s annual conference in San Diego showing that Wegovy® (semaglutide) tablets 25...
Thursday, April 2, 2026 – Friday, April 3 - Their effectiveness also depends on what else you do when you take them.
Thursday, April 2, 2026 – THURSDAY, April 2, 2026 — A popular weight loss drug may soon be more affordable for some people.
Danish pharmaceutical company Novo Nordisk has launched a subscription program for its obesity treatment Wegovy, offering lower and more...
Thursday, April 2, 2026 – THURSDAY, April 2, 2026 -- Glucagon-like peptide-1 (GLP-1) receptor agonist (RA) use is associated with delayed wound healing in patients undergoing abdominal panniculectomy, according to a study published in the April issue of Plastic and...